SEC
SlamSEC
SearchBrowseEarnings

Onconetix, Inc.

Nasdaq:ONCO
Pharmaceutical Preparations·CINCINNATI, OH
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(338 total)

TypeDateAccessionPeriodSize
425
Feb 12, 2026
0001213900-26-015214CURRENT REPORT
—
710.1 KB
8-K
Feb 12, 2026
0001213900-26-015212CURRENT REPORT
Feb 11, 2026
1.0 MB
8-K
Feb 9, 2026
0001213900-26-013724CURRENT REPORT
Feb 3, 2026
192.6 KB
DEF 14A
Jan 2, 2026
0001213900-26-000080DEFINITIVE PROXY STATEMENT
Feb 3, 2026
208.6 KB
EFFECT
Dec 23, 2025
9999999995-25-003904
—
1.9 KB
424B3
Dec 23, 2025
0001213900-25-125297PROSPECTUS
—
323.9 KB
PRE 14A
Dec 22, 2025
0001213900-25-124575PRELIMINARY PROXY STATEMENT
Dec 22, 2025
208.8 KB
S-1/A
Dec 22, 2025
0001213900-25-124018AMENDMENT NO. 1 TO FORM S-1
—
592.5 KB
3
Dec 12, 2025
0001213900-25-121329
Dec 5, 2025
3.0 KB
8-K
Dec 10, 2025
0001213900-25-120144CURRENT REPORT
Dec 5, 2025
208.3 KB
8-K
Dec 10, 2025
0001213900-25-119898CURRENT REPORT
Dec 6, 2025
222.8 KB
10-Q
Nov 13, 2025
0001213900-25-110142QUARTERLY REPORT
Sep 30, 2025
8.8 MB
424B3
Nov 10, 2025
0001213900-25-108210PROSPECTUS
—
387.0 KB
DEF 14A
Nov 10, 2025
0001213900-25-108093DEFINITIVE PROXY STATEMENT
Dec 5, 2025
817.0 KB
S-1
Nov 4, 2025
0001213900-25-106177REGISTRATION STATEMENT
—
580.7 KB
8-K
Oct 29, 2025
0001213900-25-103351CURRENT REPORT
Oct 23, 2025
187.6 KB
PRE 14A
Oct 29, 2025
0001213900-25-103182PRELIMINARY PROXY STATEMENT
Oct 28, 2025
817.1 KB
S-1
Oct 16, 2025
0001213900-25-099298REGISTRATION STATEMENT
—
631.5 KB
D
Oct 7, 2025
0001465818-25-000010
—
9.3 KB
8-K
Oct 3, 2025
0001213900-25-095847CURRENT REPORT
Oct 1, 2025
1.4 MB
8-K
Sep 26, 2025
0001213900-25-091966CURRENT REPORT
Sep 22, 2025
1.6 MB
8-K
Sep 22, 2025
0001213900-25-089845CURRENT REPORT
Sep 17, 2025
402.1 KB
8-K
Sep 4, 2025
0001213900-25-084500CURRENT REPORT
Aug 28, 2025
334.5 KB
4
Aug 19, 2025
0001213900-25-078489
Aug 15, 2025
7.3 KB
4
Aug 19, 2025
0001213900-25-078488
Aug 15, 2025
7.3 KB
25 filings shown
CEO
Schiess Ralph